KFA Private Wealth Group LLC Purchases 21 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

KFA Private Wealth Group LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,715 shares of the healthcare conglomerate’s stock after purchasing an additional 21 shares during the quarter. UnitedHealth Group comprises about 0.5% of KFA Private Wealth Group LLC’s portfolio, making the stock its 28th biggest holding. KFA Private Wealth Group LLC’s holdings in UnitedHealth Group were worth $1,429,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. Robbins Farley bought a new position in shares of UnitedHealth Group in the third quarter worth $25,000. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $26,000. CGC Financial Services LLC increased its stake in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC lifted its stake in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA increased its stake in shares of UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research analyst reports. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a research note on Thursday, April 4th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Truist Financial reissued a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Finally, Royal Bank of Canada reduced their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $570.05.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Stock Up 0.3 %

NYSE:UNH traded up $1.49 during trading hours on Friday, hitting $495.35. 2,608,554 shares of the company traded hands, compared to its average volume of 4,508,195. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a market cap of $455.76 billion, a PE ratio of 30.28, a PEG ratio of 1.41 and a beta of 0.54. The firm’s 50-day simple moving average is $485.84 and its 200-day simple moving average is $514.21.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the business posted $6.26 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.